14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 FOLD stock ended at $10.42. This is 0.774% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 3.02% from a day low at $10.26 to a day high of $10.57.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Amicus Therapeutics prices

Date Open High Low Close Volume
Nov 06, 2023 $11.54 $11.60 $11.25 $11.31 2 837 178
Nov 03, 2023 $11.14 $11.66 $11.09 $11.58 3 061 043
Nov 02, 2023 $11.22 $11.32 $10.80 $10.93 1 387 255
Nov 01, 2023 $11.01 $11.09 $10.86 $10.98 2 066 976
Oct 31, 2023 $10.80 $11.01 $10.68 $10.97 1 411 470
Oct 30, 2023 $10.77 $11.01 $10.73 $10.92 1 296 140
Oct 27, 2023 $10.84 $10.92 $10.68 $10.71 2 143 650
Oct 26, 2023 $10.90 $11.06 $10.79 $10.86 1 889 858
Oct 25, 2023 $10.90 $10.97 $10.75 $10.80 2 475 151
Oct 24, 2023 $10.93 $11.15 $10.91 $11.03 1 736 235
Oct 23, 2023 $10.83 $10.98 $10.74 $10.82 1 587 000
Oct 20, 2023 $10.35 $11.17 $10.35 $10.90 2 505 845
Oct 19, 2023 $10.66 $10.67 $10.19 $10.29 1 609 830
Oct 18, 2023 $10.63 $10.77 $10.52 $10.65 1 557 523
Oct 17, 2023 $10.52 $10.90 $10.49 $10.78 2 118 076
Oct 16, 2023 $10.49 $10.68 $10.23 $10.56 1 388 445
Oct 13, 2023 $10.22 $10.46 $10.04 $10.44 2 933 373
Oct 12, 2023 $10.83 $10.83 $10.06 $10.11 3 041 017
Oct 11, 2023 $10.85 $11.15 $10.79 $10.87 1 991 596
Oct 10, 2023 $10.85 $11.04 $10.79 $10.82 1 572 021
Oct 09, 2023 $11.02 $11.12 $10.82 $10.86 1 972 587
Oct 06, 2023 $10.98 $11.24 $10.96 $11.08 2 040 899
Oct 05, 2023 $10.76 $11.17 $10.76 $11.14 2 657 424
Oct 04, 2023 $10.98 $11.09 $10.69 $10.78 1 951 457
Oct 03, 2023 $11.03 $11.33 $10.94 $11.03 2 406 096
Click to get the best stock tips daily for free!

About Amicus Therapeutics

Amicus Therapeutics Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzym... FOLD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT